Cause of death, by non-communicable diseases, ages 5-14, male in Guyana
Guyana: Cause of death, by non-communicable diseases, ages 5-14, male was 43.3% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, male in Guyana, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
Guyana recorded 43.3% for cause of death, by non-communicable diseases, ages 5-14, male in 2021.
Compared with earlier readings it is down 7.2% on the previous year and up 32.4% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Guyana peaked at 49.2% in 2019 and was at its lowest, 32.7%, in 2010.
Guyana ranks 64th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14, male in Guyana, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 33.4% | — |
| 2010 | 32.7% | -1.9% |
| 2015 | 34.8% | +6.3% |
| 2019 | 49.2% | +41.4% |
| 2020 | 46.7% | -5.1% |
| 2021 | 43.3% | -7.2% |
Guyana compared with similar countries
- Guyana's 43.3% is below the median for high income countries, which is 57.8%, 75% of the median. (58 countries reporting)
- Guyana's 43.3% is above the median for Latin America & Caribbean, which is 40.6%, 1.1× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 33.4% | 33.4% | 33.4% | 1 |
| 2010s | 38.9% | 32.7% | 49.2% | 3 |
| 2020s | 45.0% | 43.3% | 46.7% | 2 |
Countries ranked near Guyana
More health data for Guyana
- Un projection of annual infant deaths, annual growth rate -1.59 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4509 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,225 deaths per 1,000 people (2090)
- Number of infants who die before age 1 62 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.39 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0477 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.38 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Guyana?
- Cause of death, by non-communicable diseases, ages 5-14, male in Guyana was 43.3% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Guyana?
- The highest recorded value was 49.2% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Guyana?
- The lowest recorded value was 32.7% in 2010.
- How does Guyana rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Guyana ranks 64th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Guyana?
- Over the last ten years it is up 32.4%. The long-run trend across the full record is rising.
- Where does this Guyana data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.